Affiance Financial’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$353K Buy
2,792
+18
+0.6% +$2.37K 0.05% 88
2026
Q1
$387K Hold
2,774
0.06% 84
2025
Q4
$340K Hold
2,774
0.05% 83
2025
Q3
$308K Hold
2,774
0.06% 87
2025
Q2
$308K Hold
2,774
0.06% 84
2025
Q1
$311K Sell
2,774
-757
-21% -$78.1K 0.07% 82
2024
Q4
$326K Hold
3,531
0.08% 82
2024
Q3
$296K Hold
3,531
0.07% 85
2024
Q2
$242K Buy
+3,531
New +$236K 0.06% 87
2023
Q1
Sell
-1,413
Closed -$121K 215
2022
Q4
$121K Buy
+1,413
New +$112K 0.05% 122
2017
Q4
Sell
-3,171
Closed -$257K 81
2017
Q3
$257K Sell
3,171
-100
-3% -$7.65K 0.21% 67
2017
Q2
$232K Buy
3,271
+49
+2% +$3.26K 0.18% 69
2017
Q1
$219K Sell
3,222
-4,531
-58% -$319K 0.17% 72
2016
Q4
$555K Sell
7,753
-100
-1% -$7.43K 0.44% 39
2016
Q3
$621K Buy
7,853
+200
+3% +$16.2K 0.5% 36
2016
Q2
$638K Buy
7,653
+100
+1% +$8.88K 0.54% 36
2016
Q1
$694K Buy
+7,553
New +$681K 0.66% 32

Other funds holding GILD

Affiance Financial's GILD Position: Q2 2026 in Review

Affiance Financial increased its Gilead Sciences (GILD) stake by 0.65% in Q2 2026, buying an estimated $2.37K and bringing the position to 2,792 shares worth $353K. The position accounts for 0.05% of the portfolio, ranked #88.

Affiance Financial first reported a position in GILD in Q1 2016 and has held it in 17 quarters since. The position peaked at $694K in Q1 2016. 1,014 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Affiance Financial held 2,792 shares of Gilead Sciences worth $353K as of Q2 2026.
  • Affiance Financial bought 18 Gilead Sciences shares in Q2 2026, an estimated $2.37K.
  • Gilead Sciences made up 0.05% of Affiance Financial's portfolio in Q2 2026, its #88 holding.
  • Affiance Financial first reported a position in Gilead Sciences in Q1 2016 and has held it in 17 quarters since.
  • Affiance Financial's Gilead Sciences position peaked at $694K in Q1 2016.
  • 1,014 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Affiance Financial's 13F filing for Q2 2026, filed 9 Jul 2026.